{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T16:10:15Z","timestamp":1706890215488},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00115-005-2035-1","type":"journal-article","created":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T20:31:54Z","timestamp":1138221114000},"page":"350-354","source":"Crossref","is-referenced-by-count":0,"title":["Fritz Fl\u00fcgel (1897\u20131973)"],"prefix":"10.1007","volume":"77","author":[{"given":"S.","family":"Bleich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kornhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2035_CR1","unstructured":"Baer R (2004) Lebenslauf von Fritz Fl\u00fcgel aus Best\u00e4nden der Psychiatrischen und Psychotherapeutischen Klinik mit Poliklinik Erlangen. Pers\u00f6nliche Mitteilung"},{"key":"2035_CR2","unstructured":"Bangen HC (1992) Geschichte der medikament\u00f6sen Therapie der Schizophrenie. VWB-Verlag f\u00fcr Wissenschaft und Bildung, Berlin"},{"key":"2035_CR3","first-page":"1296","volume":"31","author":"Bente","year":"1955","unstructured":"Bente D, Itil T (1955) Das Verhalten des Hirnstrombildes bei hochdosierter Behandlung mit Reserpin (Serpasil) und bei medikament\u00f6s erzeugten parkinson\u00e4hnlichen Zustandsbildern. Med Klin 31:1296\u20131301","journal-title":"Med Klin"},{"key":"2035_CR4","doi-asserted-by":"crossref","unstructured":"Bleuler E (1960) Lehrbuch der Psychiatrie, 10.\u00a0Aufl. Springer, Berlin Heidelberg New York","DOI":"10.1007\/978-3-642-52660-2"},{"key":"2035_CR5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","volume":"Toxicol","author":"Carlsson","year":"1963","unstructured":"Carlsson A, Lindquist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20:140\u2013144","journal-title":"Acta Pharmacol"},{"key":"2035_CR6","unstructured":"Delay J, Deniker P (1952) 38 cas de psychoses trait\u00e9es par la cure prolong\u00e9e et continue de 4567 R.P. Comtes rendus du Congr\u00e8s des M\u00e9decins Ali\u00e9nistes et Neurologistes de France et des pays de lanque fran\u00e7aise, Luxembourg, 21\u201327 juillet 1952. 50:503\u2013513"},{"key":"2035_CR7","unstructured":"Delay J, Deniker P (1952) Le traitement de psychoses par une m\u00e9thode neurolytique d\u00e9riv\u00e9e de l\u2019hibernoth\u00e9rapie. Comtes rendus du Congr\u00e8s des Medecins Ali\u00e9nistes et Neurologistes de France et des pays de lanque fran\u00e7aise, Luxembourg, 21\u201327 juillet 1952, 1953, pp\u00a0497\u2013502"},{"key":"2035_CR8","first-page":"1027","volume":"29","author":"Fl","year":"1953","unstructured":"Fl\u00fcgel F (1953) Neue klinische Beobachtungen zur Wirkung des Phenothiazink\u00f6rpers \u201eMegaphen\u201c auf psychische Krankheitsbilder. Med Klin 29:1027\u20131029","journal-title":"Med Klin"},{"key":"2035_CR9","first-page":"767","volume":"279","author":"Fl","year":"1954","unstructured":"Fl\u00fcgel F (1954) Erfahrungen mit Megaphen in der psychiatrischen und neurologischen Klinik. Langenbecks Arch U Dtsch Z Chir 279:767\u2013772","journal-title":"Langenbecks Arch U Dtsch Z Chir"},{"key":"2035_CR10","first-page":"2071","volume":"51","author":"Fl","year":"1956","unstructured":"Fl\u00fcgel F, Bente D (1956) Das akinetisch-abulische Syndrom. Dtsch Med Wochenschr 51:2071\u20132074","journal-title":"Dtsch Med Wochenschr"},{"key":"2035_CR11","first-page":"241","volume":"6","author":"Fl","year":"1959","unstructured":"Fl\u00fcgel F (1959) Die medikament\u00f6se Therapie der endogenen Psychosen. Nervenarzt 6:241\u2013245","journal-title":"Nervenarzt"},{"key":"2035_CR12","unstructured":"Hamon J, Paraire J, Velluz J (1952) R\u00e9marques sur l\u2019action du 4560 R.P. sur l\u2019agitation maniaque. Ann M\u00e9d Psychol 110:331\u2013335"},{"key":"2035_CR13","unstructured":"Hippius H (1996) CINP founding members, personal accounts. In: Ban TA, Ray OS (eds) A history of the CINP. JM Productions, Brentwood, pp\u00a0210\u2013213"},{"key":"2035_CR14","doi-asserted-by":"crossref","unstructured":"Kornhuber J, Wiltfang J, Bleich S (2004) The etiopathogenesis of schizophrenias. Pharmacopsychiatry 37(Suppl\u00a02):103\u2013112","DOI":"10.1055\/s-2004-832663"},{"key":"2035_CR15","unstructured":"Laborit H, Huguenard P, Alluaume R (1952) Un nouveau stabilisateur v\u00e9g\u00e9tatif (le 4560 R.P.). Presse M\u00e9d 60:206\u2013208"},{"key":"2035_CR16","unstructured":"Radouco-Thomas, Corneille, Simone (1996) The first three executives. An overview. In: Ban TA, Ray OS (eds) A history of the CINP. JM Productions, Brentwood, pp\u00a0349\u2013355"},{"key":"2035_CR17","unstructured":"Sitzungsbericht der 69. Wanderversammlung S\u00fcdwestdeutscher Neurologen und Psychiater 30.\/31. Mai, in Baden-Baden. Zentralbl Gesamte Neurol Psychiatr 1:8\u20139"},{"key":"2035_CR18","unstructured":"Swazey JP (1974) Chlorpromazine in psychiatry. A study of therapeutic innovation. MIT Press, Cambridge"},{"key":"2035_CR19","unstructured":"Wirth W (1964) Rechenschaftsbericht \u00fcber W. Wirths T\u00e4tigkeit als Vorstand des pharmakologischen Labors der Firma Bayer. Bayer Industry Services, Unternehmensgeschichte Archiv, 2\u20139"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-005-2035-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-005-2035-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-005-2035-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T15:29:06Z","timestamp":1706887746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-005-2035-1"}},"subtitle":["Fr\u00fche Forschungen auf dem Gebiet der Neuroleptika","Early research on neuroleptics"],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["2035"],"URL":"https:\/\/doi.org\/10.1007\/s00115-005-2035-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}